About Medical Consulting

Dr. KaT Zarychta is a Respected Business Development Leader and Biomedical and Medical Devices Solutions Expert with more than 20 years of global experience. 

She is quipped with a PhD from Laser Physics Laboratory in Sorbonne Paris University in France and two graduate Master degrees specialising in Physics and Biomedical Engineering, then completing Harvard's Executive Entrepreneurship, Innovation, Strategy, Negotiation & Digital Health Programs.

Over the past years she has been working as an Expert Advisor for EU Commission, where she could apply her expertise in start-up evaluations, Due Diligence, funding opportunities and growing her extensive network and excellent knowledge of the EU Institutions, Pharma, Biotech, CROs and other important Market Players in the Healthcare landscape. She was working on evaluation of over 600 companies including start-ups and SMEs. She was responsible for the European- wide new strategy and overcome major barriers in making medical technology and devices accessible to patients. She catapulted sales revenues shortly after orchestrating a successful European expansion and commercialization of innovative cancer therapy models. She successfully established new strategies to take advantage of untapped markets in Europe, APAC and the Middle East. 

With her efforts the companies have established trusted partnerships with partners spread around the glob, which led to an important increase in sales revenues.

With her strong technical background and Business acumen she has always been able to tackle the most complex challenges in Market Access and Business Development. Leveraging extensive global leadership experience navigating projects and initiatives for international organisations and businesses across the continents and continents.

Dr. Beata Prycel is a seasoned multitalented Medical Doctor, with a wide scope of expertise in Market Access, Strategy, Marketing and Business.. She graduated at Medical University of Gdansk and received an EMBA, UT Warsaw. (with London Business School, HEC Paris & Norwegian School of Economics).  She was trained in Effective Thought Leader Program, Lisbon; Value Based Selling, London ; Advance Strategy, MSI Consultancy, London; as well as Marketing Strategy & Market Building, Delivering Great Brands, Marketing Excellence Program, Market Research & Insights, The Chartered Institute of Marketing; Henley Institute of London.

She has a strong expertise in the innovative Pharma market and clinical trials in variety of therapeutical areas like: immunology, oncology, hematology, allergology, CNS, dermatology, diabetology, pulmonology and orphan drugs, serving for the Big Pharma Companies – GSK, Eli Lilly, Novartis, AMGEN, Alexion & Sanofi and CROs. The list of her achievements is including: record level on medical and business strategy & development; Strategic management approach for Pharma products portfolio & pipeline; Building clinical networking, supervision and portfolio assesment; Establishing effective collaboration with KOL’s, NGO’s  & PAG’s. Development of the digital opinion leaders management; Building successful x-functional cooperation within the big Pharma environment. Coordination of clinical trials for CEE Region; Building successful strategy for orphan diseases in CEE & Baltics countries; Development of the pipeline strategy for South-East European markets : Belarus, Ukraine, Lithuania, Latvia; Consolidation of the pipeline and portfolio of local Pharma producers; Entering on the EU market with the biggest Pharma products; Creating and successfully implementing rebranding campaign awarded on European level; Medical supervision of coordinator of international clinical projects in EU & Asia; Creating of the multi-channel strategy  for pharma business. Developing and managing the price strategy for the big value & commodity products; Improving the effectiveness of new IT technologies in Pharma Market - developing first in Poland  e-videocommunication platform for diabetes medical community and  iPAD usage project for the SR’s. She also created the market access co-promotion strategies for new products; Implemented successful stakeholders management as a member of Country Commercialization Committee process of Pharma Companies Alliance.